What is the recommended frequency to assess lurbinectedin's effectiveness?

How often should lurbinectedin effectiveness be assessed?

The recommended frequency is to assess lurbinectedin’s effectiveness every 6 weeks (for patients who receive lurbinectedin on a 21-day cycle). This is done using imaging-based tumor assessment, with evaluations at weeks 6, 12, and 18, then continuing every 6 weeks thereafter. 1

What does the 6-week schedule correspond to during treatment?

The 6-week assessment cadence aligns with the treatment cycle (21 days per cycle). By week 6, patients have completed about 2 treatment cycles, and the imaging assessments continue every 6 weeks after that point. 1

When would assessments continue or change?

The 6-week imaging assessment schedule continues as long as the patient remains on lurbinectedin and the treatment plan calls for ongoing effectiveness monitoring. If the treatment stops or a different protocol is followed, the imaging schedule would follow that new plan instead of the 6-week cadence. 1

Sources